Home/Filings/4/0001209191-21-063017
4//SEC Filing

Hudkins Robert L. 4

Accession 0001209191-21-063017

CIK 0001863127other

Filed

Nov 3, 8:00 PM ET

Accepted

Nov 4, 7:49 PM ET

Size

9.8 KB

Accession

0001209191-21-063017

Insider Transaction Report

Form 4
Period: 2021-11-02
Hudkins Robert L.
Chief Technology Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-11-02+83,62683,626 total
    Exercise: $24.15Exp: 2031-11-01Common Stock (83,626 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-11-02+7,9647,964 total
    Exercise: $24.15Exp: 2031-11-01Common Stock (7,964 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-11-02+7,9647,964 total
    Exercise: $24.15Exp: 2031-11-01Common Stock (7,964 underlying)
Footnotes (2)
  • [F1]1/48th of the shares subject to the option vest monthly following November 2, 2021, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
  • [F2]The option vests based on achievement of a performance objective.

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001880597

Filing Metadata

Form type
4
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 7:49 PM ET
Size
9.8 KB